MarketResearchFuture.com adds “Q Fever Market – 2018 Global Analysis, Growth, Trends and Opportunities Research Report forecasting to 2023” reports to its database.
The Americas account for the largest share in the global Q fever market owing to the presence of key players in the market and rising emphasis on diagnosis and treatment of rare diseases. Furthermore, the rising awareness about bacterial infection further accelerates the growth of the market. North America is the accounted for the highest market share in this region with the U.S. being the largest market followed by Canada. In the U.S, the prevalence of cardiovascular disease is found to be increasing from last few years. This is attributed to the rising prevalence of chronic diseases such as obesity and diabetes which are major risk factors for cardiovascular diseases. As per the Center for Disease Control & Prevention (CDC), in 2015, 28.4 million adults were diagnosed with cardiovascular diseases in the U.S. alone.
Europe is the second largest market and holds a noticeable share in the global Q fever market. The European market is expected to grow significantly during the forecast period owing to the availability of advanced treatment facilities, skilled medical professionals. Furthermore, extensive research and development activities for the treatment of rare disease, and increasing government support boosts the market growth.
Asia Pacific is expected to be the fastest growing market. Increasing prevalence of chronic diseases such as diabetes, cancer and bacterial infection in developing countries is the major driver for the market growth. China and India are the fastest growing regions owing to an increasing geriatric population. Also, the bacterial infection is one of the major chronic conditions affecting a large number of patients, thereby influencing the market growth. Rising awareness about the infections and availability of new treatment methods drive the market in this region. Rising healthcare expenditure and overall growth of healthcare diagnostic and treatment industry also drive the market. According to the International Diabetic Federation, about 415 million people had diabetes across the globe in 2015, which is expected to reach 642 million by 2040. It also stated that 98.4 million and 65.1 million diabetic population lived in China and India, respectively. It stated that in 2015, 3.7% of the Asian population was diagnosed with chronic heart disease, while 21% of the people had hypertension.
The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness about the Q fever, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates has the largest market share owing to the development of healthcare industry and rising availability of specialty care centers.
Some of the key players in Q fever market are Yashica Pharmaceuticals Private Limited (India) Merck & Co. (U.S.), Atox Bio (Israel), Teva Pharmaceutical Industries (Israel), Basilea Pharmaceutica Ltd. (Switzerland), and MELINTA THERAPEUTICS, INC. (U.S.), Pfizer (U.S.), Cipla Inc. (India), and others.
You can get easy access to sample report here, please click: https://www.marketresearchfuture.com/sample_request/5490 .
The infection caused by the bacterium Coxiella burnetii is termed as Q fever. Usually, Q fever is a mild disease with flu-like symptoms. Many patients have no symptoms at all while in some cases; the infection can reoccur/resurface years later. The chronic Q fever is a more deadly form of Q fever which may damage heart, liver, brain, lungs and can cause diabetes in some cases.
The global Q fever market is expecting a steady growth during the forecasted period. Growing geriatric population, increasing prevalence of infectious diseases, and technological advancement in surgery have driven the market growth. Moreover, increasing healthcare expenditure, and rising demand for the better treatment have fueled the growth of the market. However, lack of awareness about the disease in developing economies and poor reimbursement policies in developed countries may slow the growth of this market.
Taste the market data and market information presented through more than 115 market data tables and figures spread over 105 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Q fever market research report–Global forecast till 2023.”
- Pharmaceutical Manufacturers and Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
The global Q fever market is segmented on the basis of type, diagnosis, treatment, and end users.
On the basis of the type, the market is categorized into acute Q fever and chronic Q fever.
On the basis of the diagnosis, the market is segmented into imaging tests, blood test, and others. The imaging test is further sub-segmented into echocardiography, X-ray, and others.
Based on the treatment, the market is segmented into antibiotic and surgery
On the basis of the end users, the market is segmented into hospitals & clinics, diagnostic centers, surgical centers, and others.
Any query or specific requirement? Ask to our industry expert, please click: https://www.marketresearchfuture.com/enquiry/5490 .
What makes our report unique?
1) An extensive research study on the Global Q Fever market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Q Fever market.
2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.
3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.
Major TOC of Q Fever Market:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Q Fever Market, By Type
Chapter 7. Global Q Fever Market, By Diagnosis
Chapter 8. Global Q Fever Market, By Treatment
Chapter 9. Global Q Fever Market, By End User
Chapter 10. Global Q Fever Market, By Region
Chapter 11. Company Landscape
Chapter 12. Company Profiles
Chapter 13. MRFR Conclusion
Chapter 14. Appendix
LIST OF TABLES:
Table 1. Q Fever Industry Synopsis, 2017-2023
Table 2. Global Q Fever Market Estimates And Forecast, 2017-2023,
Table 3. Global Q Fever Market By Region, 2017-2023,
Table 4. Global Q Fever Market By Types, 2017-2023,
Table 5. Global Q Fever Market By Diagnosis, 2017-2023,
LIST OF FIGURES:
Figure 1. Research Process
Figure 2. Segmentation For Global Q Fever Market
Figure 3. Segmentation Market Dynamics For Q Fever Market
Figure 4. Global Q Fever Market Share, By Diagnosis 2016
Figure 5. Global Q Fever Market Share, By Treatment 2016
…CONTINUED FOR TOC
Feel free to get in touch for discounts and customized details, please click: https://www.marketresearchfuture.com/check-discount/5490 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –